Burning Rock Biotech (BNR) Short term Debt (2021)
Burning Rock Biotech has reported Short term Debt over the past 1 years, most recently at $370690.7 for Q4 2021.
- Quarterly results put Short term Debt at $370690.7 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $370690.7 (changed N/A YoY), and the annual figure for FY2021 was $367430.1, changed.
- Short term Debt for Q4 2021 was $370690.7 at Burning Rock Biotech.
- Over the last five years, Short term Debt for BNR hit a ceiling of $370690.7 in Q4 2021 and a floor of $370690.7 in Q4 2021.